211 related articles for article (PubMed ID: 24099325)
1. The presence and prognostic impact of apoptotic and nonapoptotic disseminated tumor cells in the bone marrow of primary breast cancer patients after neoadjuvant chemotherapy.
Hartkopf AD; Taran FA; Wallwiener M; Hagenbeck C; Melcher C; Krawczyk N; Hahn M; Wallwiener D; Fehm T
Breast Cancer Res; 2013; 15(5):R94. PubMed ID: 24099325
[TBL] [Abstract][Full Text] [Related]
2. Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival.
Mathiesen RR; Borgen E; Renolen A; Løkkevik E; Nesland JM; Anker G; Ostenstad B; Lundgren S; Risberg T; Mjaaland I; Kvalheim G; Lønning PE; Naume B
Breast Cancer Res; 2012 Aug; 14(4):R117. PubMed ID: 22889108
[TBL] [Abstract][Full Text] [Related]
3. Presence of apoptotic and nonapoptotic disseminated tumor cells reflects the response to neoadjuvant systemic therapy in breast cancer.
Fehm T; Becker S; Becker-Pergola G; Sotlar K; Gebauer G; Dürr-Störzer S; Neubauer H; Wallwiener D; Solomayer EF
Breast Cancer Res; 2006; 8(5):R60. PubMed ID: 17062129
[TBL] [Abstract][Full Text] [Related]
4. Does primary neoadjuvant systemic therapy eradicate minimal residual disease? Analysis of disseminated and circulating tumor cells before and after therapy.
Kasimir-Bauer S; Bittner AK; König L; Reiter K; Keller T; Kimmig R; Hoffmann O
Breast Cancer Res; 2016 Feb; 18(1):20. PubMed ID: 26868521
[TBL] [Abstract][Full Text] [Related]
5. Prognostic relevance of disseminated tumour cells from the bone marrow of early stage breast cancer patients - results from a large single-centre analysis.
Hartkopf AD; Taran FA; Wallwiener M; Hahn M; Becker S; Solomayer EF; Brucker SY; Fehm TN; Wallwiener D
Eur J Cancer; 2014 Oct; 50(15):2550-9. PubMed ID: 25096167
[TBL] [Abstract][Full Text] [Related]
6. The effect of denosumab on disseminated tumor cells (DTCs) of breast cancer patients with neoadjuvant treatment: a GeparX translational substudy.
Wimberger P; Blohmer JU; Krabisch P; Link T; Just M; Sinn BV; Simon E; Solbach C; Fehm T; Denkert C; Kühn C; Rhiem K; Tesch H; Kümmel S; Petzold A; Stötzer O; Meisel C; Kuhlmann JD; Nekljudova V; Loibl S
Breast Cancer Res; 2023 Mar; 25(1):32. PubMed ID: 36978142
[TBL] [Abstract][Full Text] [Related]
7. Prognostic relevance of induced and spontaneous apoptosis of disseminated tumor cells in primary breast cancer patients.
Krawczyk N; Hartkopf A; Banys M; Meier-Stiegen F; Staebler A; Wallwiener M; Röhm C; Hoffmann J; Hahn M; Fehm T
BMC Cancer; 2014 Jun; 14():394. PubMed ID: 24894702
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous detection of circulating and disseminated tumor cells in primary breast cancer patients following neoadjuvant chemotherapy.
Walter VP; Taran FA; Wallwiener M; Hahn M; Brucker SY; Hartkopf AD
Arch Gynecol Obstet; 2018 Mar; 297(3):785-790. PubMed ID: 29380106
[TBL] [Abstract][Full Text] [Related]
9. Disseminated tumor cells from the bone marrow of patients with nonmetastatic primary breast cancer are predictive of locoregional relapse.
Hartkopf AD; Wallwiener M; Fehm TN; Hahn M; Walter CB; Gruber I; Brucker SY; Taran FA
Ann Oncol; 2015 Jun; 26(6):1155-1160. PubMed ID: 25791636
[TBL] [Abstract][Full Text] [Related]
10. Influence of platinum-based chemotherapy on disseminated tumor cells in blood and bone marrow of patients with ovarian cancer.
Wimberger P; Heubner M; Otterbach F; Fehm T; Kimmig R; Kasimir-Bauer S
Gynecol Oncol; 2007 Nov; 107(2):331-8. PubMed ID: 17764727
[TBL] [Abstract][Full Text] [Related]
11. Influence of zoledronic acid on disseminated tumor cells in bone marrow and survival: results of a prospective clinical trial.
Banys M; Solomayer EF; Gebauer G; Janni W; Krawczyk N; Lueck HJ; Becker S; Huober J; Kraemer B; Wackwitz B; Hirnle P; Wallwiener D; Fehm T
BMC Cancer; 2013 Oct; 13():480. PubMed ID: 24128322
[TBL] [Abstract][Full Text] [Related]
12. Detection of disseminated tumor cells in locally advanced breast cancer patients before primary systemic therapy.
Solá M; Margelí M; Castellá E; Cirauqui B; Mariscal A; Rull M; Julian JF; Luna M; Vallejo V; Fraile M
Breast; 2013 Oct; 22(5):908-13. PubMed ID: 23683695
[TBL] [Abstract][Full Text] [Related]
13. Presence of disseminated tumor cells in bone marrow correlates with tumor stage and nodal involvement in cervical cancer patients.
Fehm T; Banys M; Rack B; Jäger B; Hartkopf A; Taran FA; Janni W
Int J Cancer; 2014 Feb; 134(4):925-31. PubMed ID: 23921989
[TBL] [Abstract][Full Text] [Related]
14. Detection of disseminated tumor cells from the bone marrow of patients with early breast cancer is associated with high 21-gene recurrence score.
Hartkopf AD; Wallwiener M; Kommoss S; Taran FA; Brucker SY
Breast Cancer Res Treat; 2016 Feb; 156(1):91-5. PubMed ID: 26911294
[TBL] [Abstract][Full Text] [Related]
15. Tumor cell dissemination to the bone marrow and blood is associated with poor outcome in patients with metastatic breast cancer.
Hartkopf AD; Stefanescu D; Wallwiener M; Hahn M; Becker S; Solomayer EF; Fehm TN; Brucker SY; Taran FA
Breast Cancer Res Treat; 2014 Sep; 147(2):345-51. PubMed ID: 25151295
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcome with correlation to disseminated tumor cell (DTC) status after DTC-guided secondary adjuvant treatment with docetaxel in early breast cancer.
Naume B; Synnestvedt M; Falk RS; Wiedswang G; Weyde K; Risberg T; Kersten C; Mjaaland I; Vindi L; Sommer HH; Sætersdal AB; Rypdal MC; Bendigtsen Schirmer C; Wist EA; Borgen E
J Clin Oncol; 2014 Dec; 32(34):3848-57. PubMed ID: 25366688
[TBL] [Abstract][Full Text] [Related]
17. Disseminated tumor cells as a monitoring tool for adjuvant therapy in patients with primary breast cancer.
Gruber I; Fehm T; Taran FA; Wallwiener M; Hahn M; Wallwiener D; Krawzyck N; Hoffmann J; Hartkopf AD
Breast Cancer Res Treat; 2014 Apr; 144(2):353-60. PubMed ID: 24554386
[TBL] [Abstract][Full Text] [Related]
18. Effect of ibandronate on disseminated tumor cells in the bone marrow of patients with primary breast cancer: a pilot study.
Hoffmann O; Aktas B; Goldnau C; Heubner M; Oberhoff C; Kimmig R; Kasimir-Bauer S
Anticancer Res; 2011 Oct; 31(10):3623-8. PubMed ID: 21965788
[TBL] [Abstract][Full Text] [Related]
19. Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse.
Bidard FC; Vincent-Salomon A; Gomme S; Nos C; de Rycke Y; Thiery JP; Sigal-Zafrani B; Mignot L; Sastre-Garau X; Pierga JY;
Clin Cancer Res; 2008 Jun; 14(11):3306-11. PubMed ID: 18519757
[TBL] [Abstract][Full Text] [Related]
20. Detection and prevalence of disseminated tumor cells from the bone marrow of early stage male breast cancer patients.
Hartkopf AD; Taran FA; Walter CB; Hahn M; Fehm T; Wallwiener M; Brucker SY
Breast Cancer Res Treat; 2015 Jul; 152(1):51-55. PubMed ID: 26012646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
